Fred Alger Management, LLC Scholar Rock Holding Corp Transaction History

Fred Alger Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$13.2 - $17.76 $193,815 - $260,770	-14,683 Reduced 9.07%	147,201 $2.61 Million
Q4 2023 Feb 14, 2024	BUY	$6.52 - $20.32 $1.06 Million - $3.29 Million	161,884 New	161,884 $3.04 Million
Q3 2021 Nov 15, 2021	SELL	$27.38 - $42.21 $782,931 - $1.21 Million	-28,595 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$26.34 - $46.62 $32,266 - $57,109	-1,225 Reduced 4.11%	28,595 $826,000
Q1 2021 May 17, 2021	SELL	$45.96 - $68.02 $995,861 - $1.47 Million	-21,668 Reduced 42.08%	29,820 $1.51 Million
Q4 2020 Feb 16, 2021	BUY	$13.72 - $51.57 $706,415 - $2.66 Million	51,488 New	51,488 $2.5 Million

175

75.6M

585K

862K

Ticker SRRK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,640,600
Market Cap $2.17B
Description
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.